Related Experiment Videos
Sleep and type 2 diabetes mellitus- clinical implications
1Ambika Clinic, A/224, Kasturi Plaza, Manpada Road, Dombivli (East), Thane - 421 201, Maharashtra.
The Journal of the Association of Physicians of India
|June 20, 2013
Summary
Sleep disorders significantly impact glucose metabolism, increasing risks for conditions like Type 2 Diabetes Mellitus. Effective sleep disorder management, particularly for obstructive sleep apnea (OSA), can improve insulin sensitivity and overall health.
Area of Science:
- Endocrinology
- Sleep Medicine
- Metabolic Health
Background:
- Sleep is vital for physiological functions, including glucose metabolism.
- Sleep disorders, such as obstructive sleep apnea (OSA), are increasingly linked to adverse metabolic outcomes.
- Aging also influences glucose metabolism, interacting with sleep quality and metabolic health.
Purpose of the Study:
- To explore the intricate relationship between sleep, aging, and metabolic syndrome.
- To highlight the association between various sleep disorders and Type 2 Diabetes Mellitus (Type 2 DM).
- To emphasize the role of sleep deprivation, particularly REM sleep, in obesity development.
Main Methods:
- Review of existing literature on sleep disorders and glucose metabolism.
- Analysis of common features between OSA and Type 2 DM.
- Examination of evidence linking sleep deprivation and specific sleep disorders to Type 2 DM and obesity.
Main Results:
- Obstructive sleep apnea (OSA) is a significant sleep disorder with systemic effects on glucose metabolism.
- Strong evidence connects sleep deprivation, OSA, insomnia, and restless legs syndrome with Type 2 DM.
- OSA is closely associated with insulin resistance, fatty liver, and polycystic ovary syndrome.
- Continuous positive airway pressure (CPAP) treatment for OSA improves insulin sensitivity.
Conclusions:
- Sleep disorders, especially OSA, play a critical role in glucose metabolism dysregulation and are linked to Type 2 DM.
- Recognizing and managing sleep disorders is crucial for patients with diabetes and metabolic syndrome.
- Early suspicion and treatment of sleep disorders by primary care physicians can yield significant health benefits.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...